Patent foramen ovale, systemic embolization and closure

Current Problems in Cardiology

Volumn 29, Issue 2, 2004, Pages 56-94

  Holmes Jr , David R ^a   Cohen, Howard ^a   Katz, William E ^a   Reeder, Guy S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

AIR EMBOLISM; ANTICOAGULANT THERAPY; ARTIFICIAL EMBOLISM; AUTOPSY; BLOOD OXYGENATION; BRAIN PROTECTION; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DOPPLER ECHOGRAPHY; ENDOCARDIUM; FOLLOW UP; HEART ASSIST DEVICE; HEART CATHETERIZATION; HEART FORAMEN OVALE; HEART LEFT ATRIUM PRESSURE; HEART RIGHT LEFT SHUNT; HEART SIZE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART TAMPONADE; HUMAN; IMAGE ANALYSIS; INFECTION PREVENTION; INTERNATIONAL CLASSIFICATION OF DISEASES; LUNG EMBOLISM; MIDDLE CEREBRAL ARTERY; MIGRAINE; ONSET AGE; PERSISTENT FETUS CIRCULATION; POSTOPERATIVE COMPLICATION; PRENATAL GROWTH; REVIEW; SEPTICEMIA; STANDING; SUPINE POSITION; SURGICAL TECHNIQUE; TISSUE FIXATION; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 1642545007     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2003.12.001     Document Type: Article

References (54)

1. Zahn F.W. Thrombose de plusieurs branches de la veine cave inferieure avec embolies consecutives das les arteres pulmonair, splenique, renale et iliaque droite. Rev Med Suisse Romande. 1:1881;227-237.
2. Falk V., Walther T., Krankenberg H., Mohr F.W. Trapped thrombus in a patent foramen ovale. Thorac Cardiovasc Surg. 45:1997;90-92.
3. Fabricius A.M., Kruger M., Hanke M., Mohr F.W. Caught in the act impending paradoxical embolish. Asian Cardiovasc Thorac Ann. 10:2002;342-343.
4. Maroto L.C., Molina L., Carrascal Y., Rufilanchas J.J. Intracardiac thrombus trapped in a patent foramen ovale. Eur J Cardiothorac Surg. 12:1997;807-810.
5. Marshall A.C., Lock J.E. Structural and compliant anatomy of the patent foramen ovale in patients undergoing transcatheter closure. Am Heart J. 140:2000;303-307.
6. Hanley PC, Tajik AJ, Hynes JK, Edwards WD, Reeder GS, Hagler, DJ, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol 1985;6:1370-82
7. Homma S., Di Tullio M.R., Sacco R.L., Mihalatos D., LiMandri G., Mohr J.P. Characteristics of patent foramen ovale associated with cryptogenic stroke a biplane transesophageal echocardiographic study. Stroke. 25:1994;582-586.
8. Anzola G.P. Clinical impact of patent foramen ovale diagnosis with transcranial Doppler. Eur J Ultrasound. 16:2002;11-20.
9. Devuyst G, Despland PA, Bogousslavsky J, Jeanrenaud X. Complementarity of contrast transcranial Doppler and contrast transesophageal echocardiography for the detection of patent foramen ovale in stroke patient. Eur Neurol 1997;38:21-5
10. Hagen P.T., Scholz D.G., Edwards W.P. Incidence and size of patent foramen ovale during the first 10 decades of life an autopsy study of 965 normal hearts. Mayo Clin Proc. 59:1984;17-20.
11. Overell J.R., Bone I., Lees K.R. Interatrial septal abnormalities and stroke-a meta-analysis of case-control studies. Neurology. 55:2000;1172-1179.
12. American Heart Association. Heart Disease and Stroke Statistics - 2003 update. Dallas, Tex: American Heart Association; 2002
13. Horton SC, Bunch TJ. Patent foramen ovale and stroke. Mayo Clin Proc 2004;79;79-88
14. Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O'Fallon WM, Pascoe RD, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke prevention: assessment of risk in a community. Mayo Clin Proc 1999;74:862-9
15. Agmon Y., Khandheria B.K., Messner I., Gentile F., Sicks J.D., O'Fallon W.M., et al. Comparison of frequency of patent foramen ovale by transesophageal echocardiography in patients with cerebral ischemic events versus in subjects in the general population. Am J Cardiol. 88:2001;330-332.
16. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-52
17. Foster P., Boriek A.M., Butler B.D., Gernhardt M.L., Bove A.A. Patent foramen ovale and paradoxical systemic embolism a bibliographic review. Aviat Space Environ Med. 74:2003;B1-64.
18. Di Tullio M., Sacco R.L., Gopal A., Mohr J.P., Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med. 117:1992;461-465.
19. Windecker S., Meier B. Patent foramen ovale and atrial septal aneurysm when and how should they be treated. ACC Curr J Rev. 11:2002;97-101.
20. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm or both. N Engl J Med 2001;345:1740-6
21. Mas J.L., Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. Am Heart J. 130:1995;1083-1088.
22. Agmon Y., Khandheria B.K., Meissner I., Gentile F., Whisnant J.P., Sicks J.D., et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation. 99:1999;1942-1944.
23. Wilmshurst P.T., Nightingale S., Walsh K.P., Morrison W.L. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 356:2000;1648-1651.
24. Del Sette M., Angeli S., Leandri M., Ferriero G., Bruzzone G.L., Finocchi C., et al. Migraine with aura and right-to-left shunt on transcranial Doppler a case-control study. Cerebrovasc Dis. 8:1998;327-330.
25. Morandi E., Anzola G.P., Angeli S., Melzi G., Onorato E. Transcatheter closure of patent foramen ovale a new migraine treatment? J Int Cardiol. 16:2003;39-42.
26. Sztajzel R., Genoud D., Roth S., Mermillod B., Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis. 13:2002;102-106.
27. Cantais E.P., Louge P., Suppini A., Foster P.P., Palmier B. Right-to-left shunt and risk of decompression illness with cochleovestibular and cerebral symptoms in divers case control study in 101 consecutive dive accidents. Crit Care Med. 31:2003;84-88.
28. Walsh K.P., Wilmshurst P.T., Morrison W.L. Transcatheter closure of patent foramen ovale using the amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers. Heart. 81:1999;257-261.
29. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation 2002;105:2625-31
30. Mohr J.P., Thompson J.L., Lazar R.M., Levin B., Sacco R.L., Furie K.L., et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 345:2001;1444-1451.
31. Bogousslavsky J., Garazi S., Jeanrenaud X., Aebischer N., Van Melle G. Stroke recurrence in patients with patent foramen ovale the Lausanne study. Neurology. 46:1996;1301-1305.
32. Onorato E., Melzi G., Casilli F., Pedon L., Rigatelli G., Carrozza A., et al. Patent foramen ovale with paradoxical embolism mid-term results of transcatheter closure in 256 patients. J Int Cardiol. 16:2003;43-50.
33. Comess KA, De Rook FA, Beach KW, Lytle NJ, Golby AJ, Albers GW. Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. J Am Coll Cardiol 1994;23:1598-603
34. Windecker S., Wahl A., Chatterjee T., Garachemani A., Eberli R., Seiler C., et al. Percutaneous closure of PFO in patients with paradoxical embolism long-term risk of recurrent thromboembolic events. Circulation. 101:2000;893-898.
35. Wahl A, Meier B, Haxel B, Nedeltchev K, Arnold M, Eicher E, et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001;57:1330-2
36. Dearani JA, Ugurlu BS, Danielson GK, Daly RC, McGregor CG, Mullany CJ, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999;100:II171-5
37. Homma S., Di Tullio M.R., Sacco R.L., Sciacca R.R., Smith C., Mohr J.P. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke. 28:1997;2376-2381.
38. Martin F., Sanchez P.L., Doherty E., Colon-Hernandez P.J., Delgado G., Inglessis I., et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 106:2002;1121-1126.
39. Caes F.L., Van Belleghem Y.V., Missault L.H., Coenye K.E., Van Nooten G.J. Surgical treatment of impending paradoxical embolism through patent foramen ovale. Ann Thorac Surg. 59:1995;1559-1561.
40. Hung J., Landzberg M.J., Jenkins K.J., King M.E., Lock J.E., Palacios I.F., et al. Closure of patent foramen ovale for paradoxical emboli intermediate-term risk of recurrent neurological events following transcatheter device placement. J Am Coll Cardiol. 35:2000;1311-1316.
41. Braun M.U., Fassbender D., Schoen S.P., Haass M., Schraeder R., Scholtz W., et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol. 39:2002;2019-2025.
42. Brandt R.R., Neumann T., Neuzner J., Rau M., Faude I., Hamm C.W. Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the amplatzer occlusion device no evidence for thrombus deposition with antiplatelet agents. J Am Soc Echocardiogr. 15:2002;1094-1098.
43. Bruch L., Parsi A., Grad M.O., Rux S., Burmeister T., Krebs H., et al. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism single-center experience. Circulation. 105:2002;2845-2848.
44. Deeik R.K., Thomas R.M., Sakiyalak P., Botkin S., Blakeman B., Bakhos M. Minimal access closure of patent foramen ovale is it also recommended for patients with paradoxical emboli? Ann Thoracic Surg. 74:2002;S1326-1329.
45. Devuyst G, Bogousslavsky J, Ruchat P, Jeanrenaud X, Despland PA, Regli F, et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology 1996;47:1162-6
46. Wahl A., Windecker S., Eberli F.R., Seiler C., Meier B. Percutaneous closure of patent foramen ovale in symptomatic patients. J Int Cardiol. 14:2001;203-209.
47. Meier B., Lock J.E. Contemporary management of patent foramen ovale. Circulation. 107:2003;5-9.
48. Beitzke A., Schuchlenz H., Gamillscheg A., Stein J.I., Wendelin G. Catheter closure of the persistent foramen ovale mid-term results in 162 patients. J Int Cardiol. 14:2001;223-229.
49. Hijazi Z., Wang Z., Cao Q., Koenig P., Waight D., Lang R. Transcatheter closure of atrial septal defects and patent foramen ovale under intracardiac echocardiographic guidance feasibility and comparison with transesophageal echocardiography. Catheter Cardiovasc Interv. 52:2001;194-199.
50. Bartel T., Konorza T., Arjumand J., Ebradlidze T., Eggebrecht H., Caspari G., et al. Intracardiac echocardiography is sperior to conventional monitoring for guiding device closure of interatrial communications. Circulation. 107:2003;795-797.
51. Earing M.G., Cabalka A.K., Reeder G.S., Hagler D.J. Intracardiac echocardiographic guidance during transcatheter device closure of atrial septal defect and patent foramen ovale. Catheter Cardiovasc Interv. 59:2003;155.
52. Sievert H., Horvath K., Zadan E., Krumsdorf U., Fach A., Merle H., et al. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Int Cardiol. 14:2001;261-266.
53. Khositseth A, Cabalka AK, Sweeney JP, Fortuin FD, Reeder GS, Connolly HM, et al. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism. Mayo Clin Proc 2004; 79:35-41
54. Nikomo VT, Theuma P, Maniu CV, Chandrasekaran K, Miller FA, Schaff HV, et al. Patent foramen ovale transcatheter closure device thrombosis. Mayo Clin Proc; 76:1057-61